[go: up one dir, main page]

HK1242211B - 选择用於过继细胞疗法的t细胞系及其供体的方法 - Google Patents

选择用於过继细胞疗法的t细胞系及其供体的方法 Download PDF

Info

Publication number
HK1242211B
HK1242211B HK18101773.1A HK18101773A HK1242211B HK 1242211 B HK1242211 B HK 1242211B HK 18101773 A HK18101773 A HK 18101773A HK 1242211 B HK1242211 B HK 1242211B
Authority
HK
Hong Kong
Prior art keywords
hla
patient
hla allele
cancer
pathogen
Prior art date
Application number
HK18101773.1A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1242211A1 (zh
Inventor
J 奥赖利 R
道布罗维纳 E
科伊内 冈瑟
N 哈桑 艾莎
E 普罗科普 苏珊
Original Assignee
纪念斯隆-凯特林癌症中心
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 纪念斯隆-凯特林癌症中心 filed Critical 纪念斯隆-凯特林癌症中心
Publication of HK1242211A1 publication Critical patent/HK1242211A1/zh
Publication of HK1242211B publication Critical patent/HK1242211B/zh

Links

HK18101773.1A 2014-11-05 2015-11-04 选择用於过继细胞疗法的t细胞系及其供体的方法 HK1242211B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62/075,856 2014-11-05

Publications (2)

Publication Number Publication Date
HK1242211A1 HK1242211A1 (zh) 2018-06-22
HK1242211B true HK1242211B (zh) 2021-08-06

Family

ID=

Similar Documents

Publication Publication Date Title
US12533407B2 (en) Methods of selecting T cell line and donor thereof for adoptive cellular therapy
Clute et al. Cross-reactive influenza virus–specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus–associated infectious mononucleosis
Van den Heuvel et al. Allo-HLA cross-reactivities of cytomegalovirus-, influenza-, and varicella zoster virus–specific memory T cells are shared by different healthy individuals
Kuzushima et al. Tetramer-assisted identification and characterization of epitopes recognized by HLA A* 2402–restricted Epstein-Barr virus–specific CD8+ T cells
JPWO2016203577A1 (ja) 細胞傷害性ｔ細胞エピトープペプチド及びその用途
Hasan et al. Dominant epitopes presented by prevalent HLA alleles permit wide use of banked CMVpp65 T cells in adoptive therapy
US20200017586A1 (en) Use of immune checkpoint modulators in combination with antigen-specific t cells in adoptive immunotherapy
Provenzano et al. Identification of immune dominant cytomegalovirus epitopes using quantitative real-time polymerase chain reactions to measure interferon-γ production by peptide-stimulated peripheral blood mononuclear cells
US20210000874A1 (en) Methods of selecting t cell line for adoptive cellular therapy
Milikan et al. Identification of viral antigens recognized by ocular infiltrating T cells from patients with varicella zoster virus-induced uveitis
Haveman et al. Selection of perforin expressing CD4+ adenovirus-specific T-cells with artificial antigen presenting cells
HK1242211B (zh) 选择用於过继细胞疗法的t细胞系及其供体的方法
HK1242211A1 (zh) 選擇用於過繼細胞療法的t細胞系及其供體的方法
US20230036213A1 (en) T-cell epitopes of human parainfluenza virus 3 for adoptive t-cell immunotherapy
WO2017156365A1 (en) Methods of generating antigen-specific t cells for adoptive immunotherapy
Meckiff Evolution of the human CD4+ T cell response to Epstein-Barr virus infection-analysis of systemic and local immune responses
JP2017132745A (ja) Ｈｈｖ−６ｂ特異抗原ｕ５４由来ｈｌａ−ａ２４拘束性ｃｔｌエピトープペプチド及びその使用